518 results on '"Minai, Omar A."'
Search Results
2. Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment
3. Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials
4. Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery
5. Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study
6. Heart rate recovery is an important predictor of outcomes in patients with connective tissue disease–associated pulmonary hypertension
7. Perioperative Management of the Patient with Pulmonary Hypertension
8. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema
9. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil
10. Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
11. Perioperative Risk and Management in Patients With Pulmonary Hypertension
12. Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure
13. Updating clinical endpoint definitions
14. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis
15. Effect of Obesity on B-Type Natriuretic Peptide Levels in Patients With Pulmonary Arterial Hypertension
16. Comparison of Baseline Predictors of Prognosis in Pulmonary Arterial Hypertension in Patients Surviving ≤2 Years and Those Surviving ≥5 Years After Baseline Right-Sided Cardiac Catheterization
17. Lung deflation and oxygen pulse in COPD: Results from the NETT randomized trial
18. Pulmonary hypertension: An important predictor of outcomes in patients undergoing non-cardiac surgery
19. Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management: Pulmonary Vascular Disease: The Global Perspective
20. Pulmonary hypertension in lung diseases: Survey of beliefs and practice patterns
21. Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
22. Frequency and Impact of Pulmonary Hypertension in Patients With Obstructive Sleep Apnea Syndrome
23. Bronchogenic Carcinoma after Lung Transplantation: Characteristics and Outcomes
24. Sleep Quality, Depression, and Quality of Life in Patients with Pulmonary Hypertension
25. Prevalence and Characteristics of Restless Legs Syndrome in Patients With Pulmonary Hypertension
26. Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease
27. Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension
28. Impaired Functional Capacity Predicts Mortality in Patients with Obstructive Sleep Apnea
29. Electrocardiography at Diagnosis and Close to the Time of Death in Pulmonary Arterial Hypertension
30. A 45-Year-Old Woman With Systemic Lupus Erythematosus and Progressive Dyspnea
31. Long-term Outcome in a Patient With Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia
32. Scedosporium apiospermum (Pseudoallescheria boydii) Infection in Lung Transplant Recipients
33. Restless Legs Syndrome in Lung Transplant Recipients
34. Lupus-associated pulmonary hypertension: Long-term response to vasoactive therapy
35. Predictors of Nocturnal Oxygen Desaturation in Pulmonary Arterial Hypertension
36. Lung Transplantation for Idiopathic Pulmonary Fibrosis
37. Pulmonary hypertension in patients with COPD
38. Perioperative Management of the Patient with Pulmonary Hypertension
39. Causes and Circumstances of Death in Pulmonary Arterial Hypertension
40. Therapy for α1-Antitrypsin Deficiency: Pharmacology and Clinical Recommendations
41. Pulmonary hypertension before first and second lung transplantation
42. Heart Rate Recovery Predicts Clinical Worsening in Patients with Pulmonary Arterial Hypertension
43. Safety of Diagnostic Bronchoscopy in Patients with Pulmonary Hypertension
44. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia
45. Comorbidities in Chronic Obstructive Pulmonary Disease
46. Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease
47. Cardiac Disease in Chronic Obstructive Pulmonary Disease
48. Sleep Abnormalities and Treatment in Emphysema
49. Natural History of Emphysema
50. The Evaluation and Preparation of the Patient for Lung Volume Reduction Surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.